Skip to main content
Monday, November 16, 2026Nov 16

Search for a COVID-19 vaccine heats up in China, US

Jennifer Haller, the first patient to receive a vaccine shot in the first-stage safety study clinical trial of a potential vaccine for COVID-19, the disease caused by the new coronavirus, poses for a portrait before going into the Kaiser Permanente Washington Health Research Institute to get her second dose of the vaccine, Tuesday, April 14, 2020, in Seattle. Three potential COVID-19 vaccines are making fast progress in early-stage testing in volunteers in China and the U.S., but it's still a long road to prove if they'll really work. (AP Photo/Ted S. Warren)
Jennifer Haller, the first patient to receive a vaccine shot in the first-stage safety study clinical trial of a potential vaccine for COVID-19, the disease caused by the new coronavirus, poses for a portrait before going into the Kaiser Permanente Washington Health Research Institute to get her second dose of the vaccine, Tuesday, April 14, 2020, in Seattle. Three potential COVID-19 vaccines are making fast progress in early-stage testing in volunteers in China and the U.S., but it's still a long road to prove if they'll really work. (AP Photo/Ted S. Warren)

WASHINGTON (AP) – Three potential COVID-19 vaccines are making fast progress in early-stage testing in volunteers in China and the U.S., but it’s still a long road to prove if they’ll really work.

China’s CanSino Biologics has begun the second phase of testing its vaccine candidate, China’s Ministry of Science and Technology said Tuesday.

In the U.S., a shot made by the National Institutes of Health and Moderna Inc. isn’t far behind. The first person to receive that experimental vaccine last month returned to a Seattle clinic Tuesday for a second dose.

NIH infectious disease chief Dr. Anthony Fauci told The Associated Press there are “no red flags” so far and he hoped the next, larger phase of testing could begin around June.

A third candidate, from Inovio Pharmaceuticals, began giving experimental shots for first-step safety testing last week in the U.S. and hopes to expand its studies to China.